These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33617966)

  • 1. Evaluation of the nephrotoxicity and safety of low-dose aristolochic acid, extending to the use of Xixin (Asurum), by determination of methylglyoxal and d-lactate.
    Lin CE; Lin PY; Yang WC; Huang YS; Lin TY; Chen CM; Chen HS; Lee JA; Chen SM
    J Ethnopharmacol; 2021 May; 272():113945. PubMed ID: 33617966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prednisolone on glyoxalase 1 in an inbred mouse model of aristolochic acid nephropathy using a proteomics method with fluorogenic derivatization-liquid chromatography-tandem mass spectrometry.
    Chen SM; Lin CE; Chen HH; Cheng YF; Cheng HW; Imai K
    PLoS One; 2020; 15(1):e0227838. PubMed ID: 31968011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased renal semicarbazide-sensitive amine oxidase activity and methylglyoxal levels in aristolochic acid-induced nephrotoxicity.
    Huang TC; Chen SM; Li YC; Lee JA
    Life Sci; 2014 Sep; 114(1):4-11. PubMed ID: 25107330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary d-lactate levels reflect renal function in aristolochic acid-induced nephropathy in mice.
    Huang TC; Chen SM; Li YC; Lee JA
    Biomed Chromatogr; 2013 Sep; 27(9):1100-6. PubMed ID: 23553367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy.
    Debelle F; Nortier J; Arlt VM; De Prez E; Vienne A; Salmon I; Phillips DH; Deschodt-Lanckman M; Vanherweghem JL
    Arch Toxicol; 2003 Apr; 77(4):218-26. PubMed ID: 12698237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.
    Shibutani S; Bonala RR; Rosenquist T; Rieger R; Suzuki N; Johnson F; Miller F; Grollman AP
    Int J Cancer; 2010 Sep; 127(5):1021-7. PubMed ID: 20039324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective toxicity of aristolochic acids I and II.
    Shibutani S; Dong H; Suzuki N; Ueda S; Miller F; Grollman AP
    Drug Metab Dispos; 2007 Jul; 35(7):1217-22. PubMed ID: 17392392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose darbepoetin alpha attenuates progression of a mouse model of aristolochic acid nephropathy through early tubular protection.
    Hamano Y; Aoki T; Shirai R; Hatano M; Kimura R; Ogawa M; Yokosuka O; Ueda S
    Nephron Exp Nephrol; 2010; 114(2):e69-81. PubMed ID: 19907192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.
    Lin CE; Chang WS; Lee JA; Chang TY; Huang YS; Hirasaki Y; Chen HS; Imai K; Chen SM
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29088495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in
    Liu S; Xian Z; Zhao Y; Wang L; Tian J; Pan C; Han J; Zhang Y; Li C; Yi Y; Liu C; Wang D; Meng J; Qin S; Wang F; Liang A
    Front Pharmacol; 2021; 12():761593. PubMed ID: 34899315
    [No Abstract]   [Full Text] [Related]  

  • 11. Aristolochic acid-induced accumulation of methylglyoxal and Nε-(carboxymethyl)lysine: an important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy.
    Li YC; Tsai SH; Chen SM; Chang YM; Huang TC; Huang YP; Chang CT; Lee JA
    Biochem Biophys Res Commun; 2012 Jul; 423(4):832-7. PubMed ID: 22713464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta 1/Smads signaling stimulates renal interstitial fibrosis in experimental AAN.
    Li J; Zhang Z; Wang D; Wang Y; Li Y; Wu G
    J Recept Signal Transduct Res; 2009; 29(5):280-5. PubMed ID: 19640259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine-Based Heterogeneous Linear Supramolecules Neutralized the Acute Nephrotoxicity of Aristolochic Acid by the Self-Assembly Strategy.
    Wang P; Guo W; Huang G; Zhen J; Li Y; Li T; Zhao L; Yuan K; Tian X; Huang X; Feng Y; Lei H; Xu A
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32729-32742. PubMed ID: 34247476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the difference and correlation between the contents and toxicity of aristolochic acid analogues in Aristolochia plants.
    Tian J; Liu C; Wang L; Xian Z; Zhao Y; Qin S; Yi Y; Li C; Han J; Pan C; Zhang Y; Liu S; Meng J; Tang X; Wang F; Liu M; Liang A
    J Ethnopharmacol; 2023 Oct; 315():116568. PubMed ID: 37217154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach.
    Michl J; Jennings HM; Kite GC; Ingrouille MJ; Simmonds MS; Heinrich M
    J Ethnopharmacol; 2013 Aug; 149(1):235-44. PubMed ID: 23806867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.
    Chen SM; Fan MY; Tseng CC; Ho Y; Hsu KY
    Toxicon; 2007 Aug; 50(2):180-8. PubMed ID: 17512963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study of chronic renal tubular-interstitial injury induced by Radix Aristolochiae Fangchi Extract in rats].
    Du GY; Zhou SJ; Zhao Y; Cu HF; Wang XR; Li L; Xiao YQ; Cao CY; Wu ZL; Gao SR; He R; Hui LQ; Liu BY
    Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(19):1527-32. PubMed ID: 16335826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term oral administration of Asarum heterotropoides f. mandshuricum (Maxim.) Kitag. decoction and its aristolochic acid analogs do not cause renal toxicity in mice.
    Liu M; Wang L; Qin S; Zhao Y; Liu S; Yi Y; Li C; Tian J; Liu C; Meng J; Wang Y; Zhang Y; Wang F; Pan C; Han J; Tang X; Wang L; Liang A
    J Ethnopharmacol; 2023 May; 307():116202. PubMed ID: 36708883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad7 protects against chronic aristolochic acid nephropathy in mice.
    Dai XY; Zhou L; Huang XR; Fu P; Lan HY
    Oncotarget; 2015 May; 6(14):11930-44. PubMed ID: 25883225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute nephrotoxicity of aristolochic acids in mice.
    Sato N; Takahashi D; Chen SM; Tsuchiya R; Mukoyama T; Yamagata S; Ogawa M; Yoshida M; Kondo S; Satoh N; Ueda S
    J Pharm Pharmacol; 2004 Feb; 56(2):221-9. PubMed ID: 15005881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.